247 related articles for article (PubMed ID: 26501102)
1. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
[TBL] [Abstract][Full Text] [Related]
2. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.
Lueck JD; Mankodi A; Swanson MS; Thornton CA; Dirksen RT
J Gen Physiol; 2007 Jan; 129(1):79-94. PubMed ID: 17158949
[TBL] [Abstract][Full Text] [Related]
3. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
4. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
5. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
[TBL] [Abstract][Full Text] [Related]
6. Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy.
Choi J; Dixon DM; Dansithong W; Abdallah WF; Roos KP; Jordan MC; Trac B; Lee HS; Comai L; Reddy S
Sci Rep; 2016 Aug; 6():30999. PubMed ID: 27484195
[TBL] [Abstract][Full Text] [Related]
7. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
8. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
9. Compound loss of muscleblind-like function in myotonic dystrophy.
Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
[TBL] [Abstract][Full Text] [Related]
10. Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise.
Chamberlain CM; Ranum LP
Hum Mol Genet; 2012 Nov; 21(21):4645-54. PubMed ID: 22846424
[TBL] [Abstract][Full Text] [Related]
11. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
12. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
13. A muscleblind knockout model for myotonic dystrophy.
Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
[TBL] [Abstract][Full Text] [Related]
14. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
Cerro-Herreros E; Sabater-Arcis M; Fernandez-Costa JM; Moreno N; Perez-Alonso M; Llamusi B; Artero R
Nat Commun; 2018 Jun; 9(1):2482. PubMed ID: 29946070
[TBL] [Abstract][Full Text] [Related]
15. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.
Lee KS; Cao Y; Witwicka HE; Tom S; Tapscott SJ; Wang EH
J Biol Chem; 2010 Oct; 285(44):33779-87. PubMed ID: 20709755
[TBL] [Abstract][Full Text] [Related]
17. Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice.
Poulos MG; Batra R; Li M; Yuan Y; Zhang C; Darnell RB; Swanson MS
Hum Mol Genet; 2013 Sep; 22(17):3547-58. PubMed ID: 23660517
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
[TBL] [Abstract][Full Text] [Related]
19. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
Pascual M; Vicente M; Monferrer L; Artero R
Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
[TBL] [Abstract][Full Text] [Related]
20. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1.
Kino Y; Washizu C; Oma Y; Onishi H; Nezu Y; Sasagawa N; Nukina N; Ishiura S
Nucleic Acids Res; 2009 Oct; 37(19):6477-90. PubMed ID: 19720736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
